Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 1/20 | 0.40 |
| ▸ | HPGDS | O60760 | 2/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.37 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17018687 | 0.85 | SLC1A2 (0.41) | FURINSLC1A2NPSR1ALDH1A1KDM4E | |
| SCHEMBL14725931 | 0.80 | PARP15 (0.44) | FURINHPGDSNPSR1ALDH1A1KDM4E | |
| SCHEMBL14725929 | 0.72 | SPHK2 (0.47) | FURINHPGDSALDH1A1KDM4EGAA | |
| SCHEMBL12377937 | 0.71 | GAA (0.46) | FURINALDH1A1KDM4EATMGAA | |
| SCHEMBL1696105 | 0.71 | FURIN (0.40) | FURINALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL7418948 | 0.68 | ITGB2 (0.47) | ALDH1A1KDM4ETAS1R3TAS1R1GAA | |
| SCHEMBL13950379 | 0.67 | CA12 (0.58) | ALDH1A1KDM4EGAAKMT2AHSD17B10 | |
| SCHEMBL29408688 | 0.66 | SLC1A2 (0.65) | HPGDSSLC1A2ALDH1A1GAAKMT2A | |
| SCHEMBL196586 | 0.66 | SLC1A2 (0.65) | HPGDSSLC1A2ALDH1A1GAAKMT2A | |
| SCHEMBL12377930 | 0.65 | ALDH1A1 (0.50) | NPSR1ALDH1A1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130052132-A1 | Method for Producing Radioactively Labeled Polypeptide | ARKRAY, INC. (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130052132-A1 | Method for Producing Radioactively Labeled Polypeptide | XPNPEP2, ARGLU1, XPNPEP1 | FURIN 33/4885HPGDS 3551/4885SLC1A2 524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.